Copyright
©The Author(s) 2023.
World J Diabetes. Aug 15, 2023; 14(8): 1226-1233
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1226
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1226
Biomarker candidate | Sample source | Quantitative method | Role in human body | Change | Ref. |
hs-cTnT | Human serum/plasma | ECLI | A marker of myocardial injury | Increased | [27,28] |
BNP/NT-proBNP | Human serum/plasma | CLIA | Exclude the diagnosis of left ventricular heart failure | Increased | [29-32,35] |
hs-CRP | Human serum | ELISA/LEITA | A nonspecific inflammatory marker that can predict the early myocardial damage | Increased | [39-42] |
MPO | Human serum | ELISA | An inflammatory factor in coronary artery disease | Increased | [47] |
Hcy | Human plasma | FPIA/CLIA | Induction of vascular oxidative stress and endothelial cell damage | Increased | [51-53] |
- Citation: Cheng MK, Guo YY, Kang XN, Zhang L, Wang D, Ren HH, Yuan G. Advances in cardiovascular-related biomarkers to predict diabetic peripheral neuropathy. World J Diabetes 2023; 14(8): 1226-1233
- URL: https://www.wjgnet.com/1948-9358/full/v14/i8/1226.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i8.1226